<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="5722" whole_study_id="5722" phs="000221" v="1" p="1" createDate="2009-09-29T09:23:54-05:00" modDate="2022-01-25T16:16:04-05:00" maxParentChildStudyModDate="2022-01-25T16:16:04-05:00" handle="STAMPEED_FHS" num_participants="4000"><StudyInfo accession="phs000221.v1.p1" parentAccession="phs000221.v1.p1"><BioProject id="PRJNA75565" entrez_id="75565" type="bp_admin_access"/><BioProject id="PRJNA75567" entrez_id="75567" type="bp_data_submission"/><StudyNameEntrez>STAMPEED: Family Heart Study SCAN - Genome Association Scan for Atherosclerosis Pathway Genes (Caucasians)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>analysis</StudyType></StudyTypes><Description>
&lt;p&gt;The Family Heart Study (FamHS) was funded by the National Heart, Lung, and Blood Institute (NHLBI).  It was begun in 1992 with    the ascertainment of 1,200 families, half randomly sampled, and half selected because of an excess of coronary heart disease (CHD)    or risk factor abnormalities as compared with age- and sex-specific population rates (Higgins et al. 1996).  The families, with    approximately 6,000 individuals, were sampled on the basis of information on probands from four population-based parent studies:    the Framingham Heart Study, the Utah Family Tree Study, and two Atherosclerosis Risk in Communities (ARIC) centers (Minneapolis,    and Forsyth County, NC).  A broad range of phenotypes were assessed at a clinic examination in broad domains of CHD, atherosclerosis,    cardiac and vascular function, inflammation and hemostasis, lipids and lipoproteins, blood pressure, diabetes and insulin resistance,    pulmonary function, and anthropometry (FamHS Visit 1).  Approximately 8 years later, study participants belonging to the largest    pedigrees were invited for a second clinical exam (FamHS Visit 2).  A total of 2,756 Caucasian subjects in 508 extended families    were examined.&lt;/p&gt;  &lt;p&gt;A two-phase design was adopted for the genome wide association (GWA) study.  In phase-1, 1007 subjects were chosen, equally    distributed between the upper and lower quartile of age- and sex-adjusted values for coronary artery calcification, assessed by    CT scan in Visit 2.  These subjects were chosen to be largely unrelated; 34% of the subjects were from unique families,    while 200 other subjects had 1 or more siblings selected into the sample, yielding a sample of 465 unrelated subjects.  The    remaining family members (N=1749) were genotyped in the phase-2 for replication of the top hits from the phase-1.  The results    presented here represent those for the analysis of the phase-1 case-control sample for variables assessed in FamHS Visit 1    (from 1992 to 1995) and for the variables assessed in FamHS Visit 2 (from 2002 to 2003).&lt;/p&gt;  &lt;p&gt;All subjects were typed on the Illumina HumMap 550 chip (Phase 1 genotype).  Of these, 33 (3.3%) were excluded due to    technical errors, call rates below 98%, and discrepancies between reported sex and sex-diagnostic markers.  The    final sample of 974 subjects have Visit 2 phenotypes, approximately 100 of these do not have Visit 1 phenotypes.  There was no    significant plate-to-plate variation in allele frequencies.&lt;/p&gt;   &lt;p&gt;The covariate adjustments were performed separately by sex using cubic polynomial age and clinical centers, and retaining the    terms in the stepwise regression analysis that were significant at the 5% level. Extreme outliers (&amp;gt;4 SD from the mean) were    set aside, temporarily, for the adjustments. The final phenotypes were computed for all individuals using the best mean    regression models and standardizing to 0 mean and unit variance.&lt;/p&gt;   &lt;p&gt;The FamHS has contributed GWA results in many phenotype domains (antropometric and adiposity, atherosclerosis and    coronary heart disease, lipid profile, diabetes and glicemic traits, metabolic syndrome etc) to meta-analyses and    various consortia, including Heard-Costa et al. 2009, K&amp;#246;ttgen et al. 2010, Teslovich et al. 2010, Nettleton et al. 2010,    Lango et al. 2010, Heid et al. 2010, Speliotes et al. 2010, Dupuis et al. 2010, Kraja et al. 2011.&lt;/p&gt;
 </Description><Attributions><Header title="Principal Investigator"><AttrName>Michael Province, PhD</AttrName><Institution>Washington University in St. Louis, St. Louis, MO, USA</Institution></Header><Header title="Funding Source"><AttrName>R01 HL087700</AttrName><Institution>National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution></Header></Attributions><StudyURLs><Url name="The NHLBI Family Heart Study" url="https://dsgweb.wustl.edu/fhscc/"/><Url name="FHS SCAN" url="https://dsgweb.wustl.edu/scan/"/></StudyURLs><Publications><Publication><Pubmed pmid="8651220"/></Publication><Publication><Pubmed pmid="19557197"/></Publication><Publication><Pubmed pmid="20383146"/></Publication><Publication><Pubmed pmid="20686565"/></Publication><Publication><Pubmed pmid="20693352"/></Publication><Publication><Pubmed pmid="20881960"/></Publication><Publication><Pubmed pmid="20935629"/></Publication><Publication><Pubmed pmid="20935630"/></Publication><Publication><Pubmed pmid="20081858"/></Publication><Publication><Pubmed pmid="21386085"/></Publication><Publication><Journal authors="Kilpel&#228;inen TO, Zillikens MC, Stan&#269;&#225;kov&#225; A, Finucane FM, Ried JS, Langenberg C, Zhang W, Beckmann JS, Luan J, Vandenput L, Styrkarsdottir U, Zhou Y, Smith AV, Zhao JH, Najaf A, Vedantam S, Mangino M, Haritunians T, Fu M, Feitosa MF, Kumari M, Halldorsson BV, Tikkanen E, Shin SY, Hayward C, Song C, Arnold AM, Aulchenko YS, Ben OA, Campbell H, Cupples LA, Davis KE, D&#246;ring A, Eiriksdottir G, Estrada K, Garcia M, Gieger C, Glazer NL, Guiducci C, Hofman A, Humphries SE, Isomaa B, Jacobs LC, Jula A, Karasik D, Karlsson MK, Khaw KT, Kivim&#228;ki M, Klopp N, K&#252;hnel B, Kuusisto J, Lauren K, Liu Y, Ljunggren O, Lorentzon M, Luben RN, McKnight B, Mellstr&#246;m D, Mitchell BD, Mooser V, M&#228;nnist&#246; S, O'Connell JR, Pascoe L, Peltonen L, Perola M, Psaty BM, Salomaa V, Savage DB, Semple RK, Skaric-Juric T, Sigurdsson G, Song KS, Soranzo N, Syv&#228;nen AC, Talmud PJ, Thorleifsson G, Thorsteinsdottir U, Uitterlinden AG, van Duijn CM, Vidal-Puig A, Wild SH, Wright AF, Clegg DJ, Schadt E, Wilson JF, Rudan I, Ripatti S, Borecki IB, Shuldiner AR, Ingelsson E, Jansson JO, Kaplan RC, Gudnason V, Harris TB, Groop L, Kiel DP, Rivadeneira F, Walker M, Barroso I, Vollenweider P, Waeber G, Chambers JC, Kooner JS, Spector TD, Hirschhorn JN, Stefansson K, Wichmann HR, Ohlsson C, O'Rahilly S, Wareham NJ, Speliotes EK, Fox CS, Laakso M, Loos RJF" title="Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile" journal="Nature Genetics 2011. In Press"/></Publication><Publication><Journal authors="Kanoni S, Nettleton J, Hivert MF, Ye Z, van Rooij F, Shungin D, Sonestedt E, Ngwa J, Wojczynski M, Lemaitre R, Gustafsson S, Anderson J, Tanaka T, Hindy G, Saylor G, Renstrom F, Bennett A, van Duijn C, Florez J, Fox C, Hofman A, Hoogeveen R, Houston D, Hu F, Jacques P, Johansson I, Lind L, Liu Y, McKeown N, Ordovas J, Pankow J, Sijbrands E, Syv&#228;nen AC, Uitterlinden A, Yannakoulia M, Zillikens MC, Wareham N, Prokopenko I, Bandinelli S, Forouhi N, Cupples LA, Loos R, Hallmans G, Dupuis J, Langenberg C, Ferrucci L, Kritchevsky S, McCarthy M, Ingelsson E, Borecki I, Witteman J, Orho-Melander M, Siscovick D, Meigs J, Franks P, Dedoussis G" title="Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis" journal="Diabetes 2011. In Press"/></Publication></Publications><Funding>R01 HL087700-01</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="PROVINCEM" aid="2" auth="eRA" login="PROVINCEM" fname="Michael" mname="A" lname="Province" email="mprovince@wustl.edu"><Role>PI</Role><Organization>WASHINGTON UNIVERSITY</Organization></Person><Person nedid="0010055357" aid="1" auth="cit" login="jaquishc" fname="Cashell" mname="E" lname="Jaquish" email="cj68r@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>GWAS results from the Family Heart Study (Caucasians) were partly supported by NIH grants HL087700 and HL088215.</acknowledgement_statement><ic_specific_access_term>The informed consent document signed by the Family Heart Study participants allows use of these data by investigators employed by non-profit and for-profit organizations.
Use of the data is limited only by the terms of the model Data Use Certification. </ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="434" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>The informed consent document signed by the Family Heart Study participants allows use of these data by inverstigators employed by non-profit and for-profit organizations.</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="434"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink><ConsentGroupLink cg_uid_from="434"><StudyTo study_uid="37911" name="NHLBI Big Data Analysis Heart Failure Challenge Data Collection" accession="phs001991.v1"><ConsentGroupTo uid="3884" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>